BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11522693)

  • 1. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset.
    Hillier TA; Pedula KL
    Diabetes Care; 2001 Sep; 24(9):1522-7. PubMed ID: 11522693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and BMI-related differences in risk factors for coronary artery disease in patients with type 2 diabetes mellitus.
    Bo S; Gentile L; Cavallo-Perin P; Vineis P; Ghia V
    Acta Diabetol; 1999 Sep; 36(3):147-53. PubMed ID: 10664319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients.
    Chan WB; Tong PC; Chow CC; So WY; Ng MC; Ma RC; Osaki R; Cockram CS; Chan JC
    Diabet Med; 2004 Apr; 21(4):349-53. PubMed ID: 15049937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
    De Pablos PL; Martinez J; Martinez MP; Doreste JA
    Diabetes Metab; 1998 Sep; 24(4):337-43. PubMed ID: 9805644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.
    Ferrara A; Karter AJ; Ackerson LM; Liu JY; Selby JV;
    Diabetes Care; 2001 Jul; 24(7):1144-50. PubMed ID: 11423493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk profiles in relation to newly diagnosed type 2 diabetes diagnosed by either glucose or HbA1c criteria in Chinese adults in Qingdao, China.
    Qie LY; Sun JP; Ning F; Pang ZC; Gao WG; Ren J; Nan HR; Zhang L; Qiao Q;
    Diabet Med; 2014 Aug; 31(8):920-6. PubMed ID: 24824545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity and glycemic control in patients with type 2 diabetes.
    El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between obesity, plasma immunoreactive insulin concentration and blood pressure in newly diagnosed Indian type 2 diabetic patients.
    Yajnik CS; Naik SS; Bhat DS; Joshi VM; Shelgikar KM; Alberti KG; Hockaday TD
    Diabet Med; 1993 Mar; 10(2):146-51. PubMed ID: 8458191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
    Li L; Song Q; Yang X
    J Diabetes Res; 2019; 2019():3175418. PubMed ID: 31871945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide].
    Pujante Alarcón P; Hellín Gil MD; Román LM; Ferrer Gómez M; García Zafra MV; Tébar Massó J
    Med Clin (Barc); 2012 Dec; 139(13):572-8. PubMed ID: 22209597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register.
    Steinarsson AO; Rawshani A; Gudbjörnsdottir S; Franzén S; Svensson AM; Sattar N
    Diabetologia; 2018 Mar; 61(3):599-606. PubMed ID: 29318343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.
    Hollander PA; Elbein SC; Hirsch IB; Kelley D; McGill J; Taylor T; Weiss SR; Crockett SE; Kaplan RA; Comstock J; Lucas CP; Lodewick PA; Canovatchel W; Chung J; Hauptman J
    Diabetes Care; 1998 Aug; 21(8):1288-94. PubMed ID: 9702435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.
    Yki-Järvinen H; Ryysy L; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Salo S; Seppälä P; Tulokas T; Viikari J; Taskinen MR
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4037-43. PubMed ID: 9398709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes.
    Kohler KA; McClellan WM; Ziemer DC; Kleinbaum DG; Boring JR
    Am J Kidney Dis; 2000 Nov; 36(5):903-13. PubMed ID: 11054346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age is the main determinant of glycated hemoglobin levels in a general Polish population without diabetes: The NATPOL 2011 Study.
    Symonides B; Solnica B; Placha G; Pędzich-Placha E; Rutkowski M; Bandosz P; Gaciong Z; Zdrojewski T
    Adv Clin Exp Med; 2019 May; 28(5):659-664. PubMed ID: 30684315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metabolic control on autonomic function in obese patients with newly diagnosed type 2 diabetes.
    Vanninen E; Uusitupa M; Länsimies E; Siitonen O; Laitinen J
    Diabet Med; 1993; 10(1):66-73. PubMed ID: 8435991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.